CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +14,280 | 14,280 | ||
| 2024-01-02 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +15,170 | 15,170 | ||
| 2024-01-02 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +14,280 | 14,280 | ||
| 2024-01-02 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +8,920 | 8,920 | ||
| 2024-01-02 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +14,280 | 14,280 | ||
| 2024-01-02 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2024-01-02 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +8,030 | 8,030 | ||
| 2024-01-02 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +14,280 | 14,280 | ||
| 2024-01-02 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-01-02 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2024-01-02 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +9,633 | 9,633 | ||
| 2024-01-02 | Krasney Karen EVP, GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-01-02 | Krasney Karen EVP, GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +7,140 | 7,140 | ||
| 2024-01-02 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-01-02 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +9,692 | 9,692 | ||
| 2023-10-23 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise | +2,178 | $1.39 | $3K | 2,381 |
| 2023-10-12 | Musket David B Director | Purchase | +410 | $2.75 | $1K | 31,536 |
| 2023-10-10 | COLLIER EARL M JR Director | Purchase | +10,000 | $2.83 | $28K | 26,856 |
Page 8 of 24 · 468 trades